According to Benitec Biopharma 's latest financial reports the company's total assets are $21.35 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-06-30 | $4.46 M | -25.26% |
2022-06-30 | $5.97 M | -72.06% |
2021-06-30 | $21.37 M | 84.51% |
2020-06-30 | $11.58 M | -14.23% |
2019-06-30 | $13.5 M | 16.48% |
2018-06-30 | $11.59 M | -13.36% |
2017-06-30 | $13.38 M | 20.64% |
2016-06-30 | $11.09 M | -26.12% |
2015-06-30 | $15.01 M | -33.62% |
2014-06-30 | $22.62 M | -21.27% |
2013-06-30 | $28.73 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $0.27 M | -98.73% | Bahamas |
NRC Health
NRC | $0.12 B | 473.39% | ๐บ๐ธ USA |